Ingredients For Product Liability Litigation: From FDA Actions To Foreign Labels
Executive Summary
What do plaintiffs lawyers look for in deciding whether to file a product liability suit against a pharmaceutical company?
You may also be interested in...
Dismissal Of Indictment Against Former GSK Attorney May Bode Well For Pharma
Judge rules that prosecutors gave erroneous instructions to a grand jury; if the government seeks to reindict Lauren Stevens, she can use the advice of counsel defense.
FDA Warning Letters Do Not Prove Wrongdoing, Appeals Court Finds
A state appeals court ruled that FDA warning letters are informal and advisory notifications and thus cannot be the basis of a finding that Johnson & Johnson made false and misleading statements to health care providers about Risperdal (risperidone) and Duragesic (fentanyl).
FDA Standardizing “Dear Doc” Letters To Fix Problems With Recipients As Much As Senders
FDA appears to have found problems on both the senders’ and recipients’ sides of “Dear Health Care Provider Letters” and issued guidance recommending effectiveness assessments and formatting specifications in an attempt to give the correspondence more impact.